

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of neurotransmitter secretion (GO:0046929) | 8.11464847 |
| 2 | positive regulation of amino acid transport (GO:0051957) | 7.67848335 |
| 3 | negative regulation of amino acid transport (GO:0051956) | 6.98221271 |
| 4 | phospholipid scrambling (GO:0017121) | 6.97082695 |
| 5 | positive regulation of catecholamine secretion (GO:0033605) | 6.75853940 |
| 6 | cullin deneddylation (GO:0010388) | 6.73237976 |
| 7 | negative regulation of neurotransmitter transport (GO:0051589) | 6.61061397 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.36220685 |
| 9 | protein deneddylation (GO:0000338) | 6.08405019 |
| 10 | regulation of glutamate secretion (GO:0014048) | 6.08197818 |
| 11 | serotonin receptor signaling pathway (GO:0007210) | 6.01800985 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.79076494 |
| 13 | proteasome assembly (GO:0043248) | 5.73521903 |
| 14 | ribosome assembly (GO:0042255) | 5.43281905 |
| 15 | branched-chain amino acid catabolic process (GO:0009083) | 5.20897003 |
| 16 | protein neddylation (GO:0045116) | 4.99939729 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.64212087 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.64212087 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.64212087 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 4.64212087 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 4.64212087 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 4.64212087 |
| 23 | respiratory burst (GO:0045730) | 4.46548878 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.32021522 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.29820415 |
| 26 | response to peptidoglycan (GO:0032494) | 4.29104667 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.19916235 |
| 28 | branched-chain amino acid metabolic process (GO:0009081) | 4.07523559 |
| 29 | intestinal epithelial cell development (GO:0060576) | 4.05953361 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 4.05597908 |
| 31 | pharyngeal system development (GO:0060037) | 4.04846838 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 4.00863987 |
| 33 | microglial cell activation (GO:0001774) | 3.97245114 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.96087041 |
| 35 | regulation of amino acid transport (GO:0051955) | 3.95552949 |
| 36 | negative regulation of interleukin-17 production (GO:0032700) | 3.92982013 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.83531965 |
| 38 | neutrophil activation (GO:0042119) | 3.75331216 |
| 39 | granulocyte activation (GO:0036230) | 3.73276926 |
| 40 | phagosome maturation (GO:0090382) | 3.71456508 |
| 41 | regulation of dopamine secretion (GO:0014059) | 3.65447139 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.56935010 |
| 43 | DNA replication checkpoint (GO:0000076) | 3.56263997 |
| 44 | mast cell activation (GO:0045576) | 3.47565841 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46666561 |
| 46 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.44592955 |
| 47 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.39295237 |
| 48 | platelet dense granule organization (GO:0060155) | 3.39276055 |
| 49 | superoxide anion generation (GO:0042554) | 3.38855008 |
| 50 | negative regulation of amine transport (GO:0051953) | 3.38713749 |
| 51 | negative regulation of heart rate (GO:0010459) | 3.38519372 |
| 52 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.38357602 |
| 53 | muscle cell fate commitment (GO:0042693) | 3.36102980 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.35394227 |
| 55 | macrophage activation (GO:0042116) | 3.32713027 |
| 56 | defense response to protozoan (GO:0042832) | 3.29389435 |
| 57 | N-glycan processing (GO:0006491) | 3.28709745 |
| 58 | leukocyte degranulation (GO:0043299) | 3.27845379 |
| 59 | negative regulation of mast cell activation (GO:0033004) | 3.27181883 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26535623 |
| 61 | response to host immune response (GO:0052572) | 3.26279847 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26279847 |
| 63 | protein K11-linked ubiquitination (GO:0070979) | 3.24920944 |
| 64 | cellular response to interferon-beta (GO:0035458) | 3.19922560 |
| 65 | regulation of mast cell activation (GO:0033003) | 3.19027212 |
| 66 | regulation of membrane lipid distribution (GO:0097035) | 3.13641743 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.12808048 |
| 68 | B cell mediated immunity (GO:0019724) | 3.12511632 |
| 69 | early endosome to late endosome transport (GO:0045022) | 3.11864900 |
| 70 | positive regulation of amine transport (GO:0051954) | 3.10133660 |
| 71 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.09171636 |
| 72 | neural tube formation (GO:0001841) | 3.09073729 |
| 73 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.08691404 |
| 74 | leukocyte aggregation (GO:0070486) | 3.07752366 |
| 75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.05688518 |
| 76 | cellular response to zinc ion (GO:0071294) | 3.05450865 |
| 77 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.04685561 |
| 78 | reactive oxygen species biosynthetic process (GO:1903409) | 3.03823062 |
| 79 | myeloid leukocyte activation (GO:0002274) | 3.03193451 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 3.02210565 |
| 81 | regulation of antigen processing and presentation (GO:0002577) | 3.01196874 |
| 82 | leukocyte mediated cytotoxicity (GO:0001909) | 2.99923740 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.99824028 |
| 84 | positive regulation of organic acid transport (GO:0032892) | 2.98128607 |
| 85 | positive regulation of interferon-beta production (GO:0032728) | 2.96400892 |
| 86 | neutrophil mediated immunity (GO:0002446) | 2.95038445 |
| 87 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.94861263 |
| 88 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.93074459 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92903179 |
| 90 | cellular response to type I interferon (GO:0071357) | 2.92564913 |
| 91 | type I interferon signaling pathway (GO:0060337) | 2.92564913 |
| 92 | response to interferon-beta (GO:0035456) | 2.91975977 |
| 93 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.91634081 |
| 94 | response to protozoan (GO:0001562) | 2.90571214 |
| 95 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89871115 |
| 96 | regulation of chemokine biosynthetic process (GO:0045073) | 2.87441141 |
| 97 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.87395283 |
| 98 | actin nucleation (GO:0045010) | 2.86918070 |
| 99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86271036 |
| 100 | response to host (GO:0075136) | 2.86271036 |
| 101 | response to host defenses (GO:0052200) | 2.86271036 |
| 102 | response to type I interferon (GO:0034340) | 2.85917077 |
| 103 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85735869 |
| 104 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84485774 |
| 105 | nucleotide transmembrane transport (GO:1901679) | 2.84437141 |
| 106 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83157064 |
| 107 | positive regulation of mast cell activation (GO:0033005) | 2.82762951 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.82308208 |
| 109 | histamine secretion (GO:0001821) | 2.82290225 |
| 110 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81559614 |
| 111 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.81223093 |
| 112 | adenosine metabolic process (GO:0046085) | 2.80692614 |
| 113 | signal peptide processing (GO:0006465) | 2.80022787 |
| 114 | positive regulation of interleukin-12 production (GO:0032735) | 2.79152486 |
| 115 | myeloid dendritic cell differentiation (GO:0043011) | 2.77809855 |
| 116 | regulation of monocyte chemotaxis (GO:0090025) | 2.76462280 |
| 117 | regulation of interleukin-17 production (GO:0032660) | 2.75428773 |
| 118 | phagocytosis, engulfment (GO:0006911) | 2.75104804 |
| 119 | B cell receptor signaling pathway (GO:0050853) | 2.73076613 |
| 120 | natural killer cell mediated immunity (GO:0002228) | 2.70771696 |
| 121 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.70771696 |
| 122 | cellular response to exogenous dsRNA (GO:0071360) | 2.70335715 |
| 123 | positive regulation of lymphocyte migration (GO:2000403) | 2.70287220 |
| 124 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.69950545 |
| 125 | eosinophil chemotaxis (GO:0048245) | 2.68345099 |
| 126 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.67591207 |
| 127 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.67227885 |
| 128 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.66681665 |
| 129 | positive regulation of mast cell degranulation (GO:0043306) | 2.66681665 |
| 130 | positive regulation of macrophage differentiation (GO:0045651) | 2.66093785 |
| 131 | germinal center formation (GO:0002467) | 2.66043840 |
| 132 | regulation of fever generation (GO:0031620) | 2.65411326 |
| 133 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.65280306 |
| 134 | DNA double-strand break processing (GO:0000729) | 2.65151433 |
| 135 | positive regulation of protein autophosphorylation (GO:0031954) | 2.64098992 |
| 136 | xenobiotic catabolic process (GO:0042178) | 2.63791448 |
| 137 | mast cell degranulation (GO:0043303) | 2.62093424 |
| 138 | mast cell activation involved in immune response (GO:0002279) | 2.62093424 |
| 139 | negative regulation of organic acid transport (GO:0032891) | 2.61559461 |
| 140 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61330100 |
| 141 | sequestering of actin monomers (GO:0042989) | 2.60976969 |
| 142 | myeloid leukocyte mediated immunity (GO:0002444) | 2.60338545 |
| 143 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.60212182 |
| 144 | female gonad development (GO:0008585) | 2.59945341 |
| 145 | positive regulation of heat generation (GO:0031652) | 2.59383411 |
| 146 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.59275750 |
| 147 | intracellular pH reduction (GO:0051452) | 2.58766021 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.58698832 |
| 149 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.58579335 |
| 150 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.58579335 |
| 151 | NADH dehydrogenase complex assembly (GO:0010257) | 2.58579335 |
| 152 | lymphocyte chemotaxis (GO:0048247) | 2.58161109 |
| 153 | respiratory chain complex IV assembly (GO:0008535) | 2.58110717 |
| 154 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.56467334 |
| 155 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.52876342 |
| 156 | amino acid salvage (GO:0043102) | 2.50595740 |
| 157 | L-methionine salvage (GO:0071267) | 2.50595740 |
| 158 | L-methionine biosynthetic process (GO:0071265) | 2.50595740 |
| 159 | protein complex biogenesis (GO:0070271) | 2.49373194 |
| 160 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.47848278 |
| 161 | negative regulation of membrane potential (GO:0045837) | 2.47265538 |
| 162 | protein prenylation (GO:0018342) | 2.47170132 |
| 163 | prenylation (GO:0097354) | 2.47170132 |
| 164 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.46076906 |
| 165 | ribonucleoprotein complex disassembly (GO:0032988) | 2.45499034 |
| 166 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.45256702 |
| 167 | response to nitrosative stress (GO:0051409) | 2.44501774 |
| 168 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.42281644 |
| 169 | chaperone-mediated protein transport (GO:0072321) | 2.41169067 |
| 170 | C-terminal protein lipidation (GO:0006501) | 2.40873323 |
| 171 | mannose metabolic process (GO:0006013) | 2.40742383 |
| 172 | cellular glucuronidation (GO:0052695) | 2.40007889 |
| 173 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.39997360 |
| 174 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.39505319 |
| 175 | uronic acid metabolic process (GO:0006063) | 2.38897663 |
| 176 | glucuronate metabolic process (GO:0019585) | 2.38897663 |
| 177 | regulation of relaxation of muscle (GO:1901077) | 2.38518873 |
| 178 | organelle disassembly (GO:1903008) | 2.35293472 |
| 179 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.34472453 |
| 180 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.34472453 |
| 181 | isotype switching (GO:0045190) | 2.34472453 |
| 182 | kynurenine metabolic process (GO:0070189) | 2.34132526 |
| 183 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.32510609 |
| 184 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.32276031 |
| 185 | negative regulation of ligase activity (GO:0051352) | 2.32276031 |
| 186 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.31928976 |
| 187 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.31671167 |
| 188 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.30476462 |
| 189 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.28024843 |
| 190 | regulation of cilium movement (GO:0003352) | 2.27379144 |
| 191 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.26528856 |
| 192 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.25494443 |
| 193 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.23474687 |
| 194 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.22045876 |
| 195 | C-terminal protein amino acid modification (GO:0018410) | 2.21632006 |
| 196 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.17656211 |
| 197 | lactate metabolic process (GO:0006089) | 2.17446441 |
| 198 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.17150225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.01758792 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.62101374 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71656762 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.47340965 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.94218179 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.81106366 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56406996 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28308049 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05705882 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04736709 |
| 11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04709255 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.85777587 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80005022 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60542640 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.60124143 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55994748 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52991549 |
| 18 | EWS_26573619_Chip-Seq_HEK293_Human | 2.47528918 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.29741510 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.99652401 |
| 21 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.97923101 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97255323 |
| 23 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96654252 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.96009948 |
| 25 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88090563 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.87329092 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84289311 |
| 28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.82817821 |
| 29 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.81271198 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81082987 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77816918 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.73663208 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73604823 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73348293 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70879869 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70222935 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68891489 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66295456 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.64708091 |
| 40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63347701 |
| 41 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.62670402 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.60789870 |
| 43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59840340 |
| 44 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.59453188 |
| 45 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59192313 |
| 46 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.58596072 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58113605 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57197756 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.56419018 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54799711 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53650417 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53113893 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.51995958 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.51157358 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.49968687 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47901847 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46535513 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45423550 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44848724 |
| 60 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42494132 |
| 61 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.38515055 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38464389 |
| 63 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38137588 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37693652 |
| 65 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36875170 |
| 66 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36875170 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36000996 |
| 68 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.35224174 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34275218 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33581898 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33406350 |
| 72 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32999758 |
| 73 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32341770 |
| 74 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32209313 |
| 75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31874589 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31050689 |
| 77 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30845119 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30570501 |
| 79 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30092413 |
| 80 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30076378 |
| 81 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.29270927 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28816211 |
| 83 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.27646494 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25660785 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24612430 |
| 86 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.23867272 |
| 87 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.23478434 |
| 88 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.23399624 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22390096 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22310277 |
| 91 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.22165018 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21591748 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21591748 |
| 94 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21423741 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21285833 |
| 96 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.20737145 |
| 97 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20208964 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19627226 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18711308 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 1.16556910 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16427085 |
| 102 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16218293 |
| 103 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15860776 |
| 104 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.15804594 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15435804 |
| 106 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15435804 |
| 107 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14443593 |
| 108 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.14391134 |
| 109 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.13615442 |
| 110 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12691380 |
| 111 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11326453 |
| 112 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11106033 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10490803 |
| 114 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10419744 |
| 115 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.10404511 |
| 116 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09891624 |
| 117 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09001455 |
| 118 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07979173 |
| 119 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07805102 |
| 120 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07195343 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06982929 |
| 122 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06537515 |
| 123 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06480256 |
| 124 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.06276487 |
| 125 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05971425 |
| 126 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.05756573 |
| 127 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05643563 |
| 128 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05369084 |
| 129 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05299930 |
| 130 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05206137 |
| 131 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.04625795 |
| 132 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.04625795 |
| 133 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04551157 |
| 134 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04498792 |
| 135 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03924393 |
| 136 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03562713 |
| 137 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03063340 |
| 138 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02412450 |
| 139 | MYB_26560356_Chip-Seq_TH1_Human | 1.01712207 |
| 140 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99422511 |
| 141 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99305007 |
| 142 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98194860 |
| 143 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.97160559 |
| 144 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95943501 |
| 145 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94244490 |
| 146 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93524505 |
| 147 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92728093 |
| 148 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.92677415 |
| 149 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87890810 |
| 150 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.87004689 |
| 151 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.86122611 |
| 152 | VDR_22108803_ChIP-Seq_LS180_Human | 0.85933394 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83362309 |
| 154 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.83227574 |
| 155 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82779080 |
| 156 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81401499 |
| 157 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.81145906 |
| 158 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80471523 |
| 159 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.80320015 |
| 160 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80068794 |
| 161 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79248650 |
| 162 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79048431 |
| 163 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78445498 |
| 164 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.78434918 |
| 165 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78188228 |
| 166 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.78041516 |
| 167 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76544169 |
| 168 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.75465644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.99478763 |
| 2 | MP0008961_abnormal_basal_metabolism | 3.96922677 |
| 3 | MP0009785_altered_susceptibility_to | 3.88138830 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.75935668 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 3.60779285 |
| 6 | MP0004215_abnormal_myocardial_fiber | 3.44841776 |
| 7 | MP0002822_catalepsy | 3.35780472 |
| 8 | MP0003436_decreased_susceptibility_to | 3.24724178 |
| 9 | MP0002419_abnormal_innate_immunity | 3.06488835 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.98068645 |
| 11 | MP0005671_abnormal_response_to | 2.86944740 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.86573061 |
| 13 | MP0003724_increased_susceptibility_to | 2.79091114 |
| 14 | MP0005025_abnormal_response_to | 2.73562311 |
| 15 | MP0006082_CNS_inflammation | 2.68664125 |
| 16 | MP0002102_abnormal_ear_morphology | 2.67759284 |
| 17 | MP0004510_myositis | 2.65556255 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.54117076 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.50227908 |
| 20 | MP0003303_peritoneal_inflammation | 2.50090483 |
| 21 | MP0004484_altered_response_of | 2.39781360 |
| 22 | MP0001790_abnormal_immune_system | 2.38928667 |
| 23 | MP0005387_immune_system_phenotype | 2.38928667 |
| 24 | MP0002723_abnormal_immune_serum | 2.38882148 |
| 25 | MP0002234_abnormal_pharynx_morphology | 2.38208508 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.32571330 |
| 27 | MP0003195_calcinosis | 2.32554062 |
| 28 | MP0001819_abnormal_immune_cell | 2.28117640 |
| 29 | MP0001800_abnormal_humoral_immune | 2.27231417 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.26127075 |
| 31 | MP0003880_abnormal_central_pattern | 2.12707374 |
| 32 | MP0000685_abnormal_immune_system | 2.07120622 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.98666862 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.98114370 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.93590962 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.92760053 |
| 37 | MP0008058_abnormal_DNA_repair | 1.88388552 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.86868439 |
| 39 | MP0001853_heart_inflammation | 1.85343614 |
| 40 | MP0002006_tumorigenesis | 1.84039551 |
| 41 | MP0000343_altered_response_to | 1.80503651 |
| 42 | MP0001529_abnormal_vocalization | 1.72224184 |
| 43 | MP0003075_altered_response_to | 1.69121038 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.61596550 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.59906658 |
| 46 | MP0002090_abnormal_vision | 1.58457401 |
| 47 | MP0000716_abnormal_immune_system | 1.55209926 |
| 48 | MP0002405_respiratory_system_inflammati | 1.52873108 |
| 49 | MP0000749_muscle_degeneration | 1.49224743 |
| 50 | MP0008775_abnormal_heart_ventricle | 1.49103738 |
| 51 | MP0002398_abnormal_bone_marrow | 1.48584278 |
| 52 | MP0009764_decreased_sensitivity_to | 1.48430944 |
| 53 | MP0005310_abnormal_salivary_gland | 1.44581362 |
| 54 | MP0006072_abnormal_retinal_apoptosis | 1.44290652 |
| 55 | MP0003786_premature_aging | 1.43523453 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.41887634 |
| 57 | MP0002736_abnormal_nociception_after | 1.39386375 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.39240971 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.37502855 |
| 60 | MP0004859_abnormal_synaptic_plasticity | 1.35800822 |
| 61 | MP0008469_abnormal_protein_level | 1.35441442 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.33304101 |
| 63 | MP0005253_abnormal_eye_physiology | 1.31550081 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.30503689 |
| 65 | MP0005166_decreased_susceptibility_to | 1.29747770 |
| 66 | MP0003448_altered_tumor_morphology | 1.29684647 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.29619261 |
| 68 | MP0003868_abnormal_feces_composition | 1.27886278 |
| 69 | MP0008877_abnormal_DNA_methylation | 1.27782733 |
| 70 | MP0004036_abnormal_muscle_relaxation | 1.26622268 |
| 71 | MP0003011_delayed_dark_adaptation | 1.26434567 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.25240269 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.24836687 |
| 74 | MP0000858_altered_metastatic_potential | 1.24083017 |
| 75 | MP0002429_abnormal_blood_cell | 1.23298809 |
| 76 | MP0010094_abnormal_chromosome_stability | 1.21115403 |
| 77 | MP0003950_abnormal_plasma_membrane | 1.20559271 |
| 78 | MP0000604_amyloidosis | 1.20148887 |
| 79 | MP0004947_skin_inflammation | 1.15219421 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 1.14140657 |
| 81 | MP0000516_abnormal_urinary_system | 1.14140657 |
| 82 | MP0001968_abnormal_touch/_nociception | 1.12218916 |
| 83 | MP0001545_abnormal_hematopoietic_system | 1.11935201 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.11935201 |
| 85 | MP0002722_abnormal_immune_system | 1.11407484 |
| 86 | MP0003828_pulmonary_edema | 1.11097469 |
| 87 | MP0005174_abnormal_tail_pigmentation | 1.10203511 |
| 88 | MP0005171_absent_coat_pigmentation | 1.10167746 |
| 89 | MP0002998_abnormal_bone_remodeling | 1.09849950 |
| 90 | MP0002972_abnormal_cardiac_muscle | 1.08914691 |
| 91 | MP0008260_abnormal_autophagy | 1.08646651 |
| 92 | MP0005085_abnormal_gallbladder_physiolo | 1.07661846 |
| 93 | MP0005620_abnormal_muscle_contractility | 1.07569766 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 1.06774293 |
| 95 | MP0005164_abnormal_response_to | 1.06132022 |
| 96 | MP0010386_abnormal_urinary_bladder | 1.05946604 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 1.04380497 |
| 98 | MP0008872_abnormal_physiological_respon | 1.04123189 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 1.03647810 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02902130 |
| 101 | MP0001984_abnormal_olfaction | 1.02723729 |
| 102 | MP0003690_abnormal_glial_cell | 1.02371341 |
| 103 | MP0005332_abnormal_amino_acid | 1.01940156 |
| 104 | MP0004142_abnormal_muscle_tone | 1.01569761 |
| 105 | MP0002396_abnormal_hematopoietic_system | 1.01471803 |
| 106 | MP0005365_abnormal_bile_salt | 1.00160372 |
| 107 | MP0005266_abnormal_metabolism | 0.99803763 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.99290814 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.98620567 |
| 110 | MP0001764_abnormal_homeostasis | 0.98012332 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.97683419 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.96472439 |
| 113 | MP0005551_abnormal_eye_electrophysiolog | 0.95073611 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.94802417 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.93498891 |
| 116 | MP0009697_abnormal_copulation | 0.92815528 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.92500563 |
| 118 | MP0003252_abnormal_bile_duct | 0.92415981 |
| 119 | MP0001501_abnormal_sleep_pattern | 0.92299497 |
| 120 | MP0008932_abnormal_embryonic_tissue | 0.86049617 |
| 121 | MP0002064_seizures | 0.85911145 |
| 122 | MP0003763_abnormal_thymus_physiology | 0.85827615 |
| 123 | MP0000372_irregular_coat_pigmentation | 0.85709973 |
| 124 | MP0003718_maternal_effect | 0.84361068 |
| 125 | MP0009745_abnormal_behavioral_response | 0.84300912 |
| 126 | MP0000613_abnormal_salivary_gland | 0.83609626 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.82162824 |
| 128 | MP0005385_cardiovascular_system_phenoty | 0.82060012 |
| 129 | MP0001544_abnormal_cardiovascular_syste | 0.82060012 |
| 130 | MP0009046_muscle_twitch | 0.81172247 |
| 131 | MP0003137_abnormal_impulse_conducting | 0.81071613 |
| 132 | MP0003186_abnormal_redox_activity | 0.80317565 |
| 133 | MP0008007_abnormal_cellular_replicative | 0.79561922 |
| 134 | MP0004883_abnormal_blood_vessel | 0.79485588 |
| 135 | MP0002735_abnormal_chemical_nociception | 0.79357631 |
| 136 | MP0004085_abnormal_heartbeat | 0.78960968 |
| 137 | MP0001188_hyperpigmentation | 0.78620524 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.78536726 |
| 139 | MP0003646_muscle_fatigue | 0.78255034 |
| 140 | MP0006054_spinal_hemorrhage | 0.77053828 |
| 141 | MP0008057_abnormal_DNA_replication | 0.75096760 |
| 142 | MP0005390_skeleton_phenotype | 0.73636994 |
| 143 | MP0001542_abnormal_bone_strength | 0.72775838 |
| 144 | MP0002332_abnormal_exercise_endurance | 0.71745304 |
| 145 | MP0001664_abnormal_digestion | 0.70072692 |
| 146 | MP0005330_cardiomyopathy | 0.69183372 |
| 147 | MP0003635_abnormal_synaptic_transmissio | 0.68858178 |
| 148 | MP0008004_abnormal_stomach_pH | 0.68722354 |
| 149 | MP0002876_abnormal_thyroid_physiology | 0.68593197 |
| 150 | MP0003633_abnormal_nervous_system | 0.68389351 |
| 151 | MP0004147_increased_porphyrin_level | 0.67930695 |
| 152 | MP0000569_abnormal_digit_pigmentation | 0.67561139 |
| 153 | MP0002063_abnormal_learning/memory/cond | 0.67150547 |
| 154 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67108268 |
| 155 | MP0001986_abnormal_taste_sensitivity | 0.66502226 |
| 156 | MP0001666_abnormal_nutrient_absorption | 0.66102429 |
| 157 | MP0003866_abnormal_defecation | 0.65594161 |
| 158 | MP0005636_abnormal_mineral_homeostasis | 0.65475572 |
| 159 | MP0008995_early_reproductive_senescence | 0.65372151 |
| 160 | MP0001191_abnormal_skin_condition | 0.65241276 |
| 161 | MP0001756_abnormal_urination | 0.64246271 |
| 162 | MP0000249_abnormal_blood_vessel | 0.63477316 |
| 163 | MP0005165_increased_susceptibility_to | 0.63318387 |
| 164 | MP0010307_abnormal_tumor_latency | 0.61836014 |
| 165 | MP0002933_joint_inflammation | 0.61554779 |
| 166 | MP0000681_abnormal_thyroid_gland | 0.61430501 |
| 167 | MP0001663_abnormal_digestive_system | 0.60197032 |
| 168 | MP0002095_abnormal_skin_pigmentation | 0.60038520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.40919544 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.71388686 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.93850890 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.75999722 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.52939464 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.33587001 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.10285942 |
| 8 | Myositis (HP:0100614) | 4.10085428 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.03837076 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.02478362 |
| 11 | Cerebral edema (HP:0002181) | 3.93360960 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.88378339 |
| 13 | Agnosia (HP:0010524) | 3.85768517 |
| 14 | Methylmalonic acidemia (HP:0002912) | 3.82819219 |
| 15 | Obstructive lung disease (HP:0006536) | 3.76044388 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.76044388 |
| 17 | Menorrhagia (HP:0000132) | 3.74099416 |
| 18 | Recurrent skin infections (HP:0001581) | 3.67169984 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.66259969 |
| 20 | Orchitis (HP:0100796) | 3.56916966 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.56261255 |
| 22 | Optic neuritis (HP:0100653) | 3.56261255 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 3.54634472 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 3.51257713 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45418340 |
| 26 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.41099392 |
| 27 | Short 1st metacarpal (HP:0010034) | 3.41099392 |
| 28 | Stomatitis (HP:0010280) | 3.33158117 |
| 29 | Gingivitis (HP:0000230) | 3.29452478 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.23359607 |
| 31 | Increased IgM level (HP:0003496) | 3.17293825 |
| 32 | Prostate neoplasm (HP:0100787) | 3.07380927 |
| 33 | Disinhibition (HP:0000734) | 3.03309693 |
| 34 | Abnormality of the 1st metacarpal (HP:0010009) | 2.99530903 |
| 35 | Progressive macrocephaly (HP:0004481) | 2.97714640 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.97297655 |
| 37 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.95958994 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 2.91310687 |
| 39 | Ketosis (HP:0001946) | 2.90903663 |
| 40 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.90801076 |
| 41 | Basal ganglia calcification (HP:0002135) | 2.87638879 |
| 42 | Exercise-induced muscle cramps (HP:0003710) | 2.87517848 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.85569549 |
| 44 | Chronic otitis media (HP:0000389) | 2.84550512 |
| 45 | Acute encephalopathy (HP:0006846) | 2.84073686 |
| 46 | Recurrent viral infections (HP:0004429) | 2.83644416 |
| 47 | Stenosis of the external auditory canal (HP:0000402) | 2.80580282 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79856665 |
| 49 | Increased CSF lactate (HP:0002490) | 2.79180659 |
| 50 | Abnormality of the renal collecting system (HP:0004742) | 2.77563917 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76816562 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76816562 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76816562 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.76178569 |
| 55 | Hyperalaninemia (HP:0003348) | 2.76178569 |
| 56 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.76178569 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.74313587 |
| 58 | Methylmalonic aciduria (HP:0012120) | 2.74231356 |
| 59 | Dyschromatopsia (HP:0007641) | 2.71206682 |
| 60 | Recurrent pneumonia (HP:0006532) | 2.69425391 |
| 61 | Abnormality of vitamin B metabolism (HP:0004340) | 2.68855162 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.68815968 |
| 63 | Cellulitis (HP:0100658) | 2.68780798 |
| 64 | Vasculitis (HP:0002633) | 2.68203905 |
| 65 | Meningitis (HP:0001287) | 2.65719826 |
| 66 | Hepatic necrosis (HP:0002605) | 2.65607009 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.64201391 |
| 68 | Lethargy (HP:0001254) | 2.61199160 |
| 69 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.60567745 |
| 70 | Hepatocellular necrosis (HP:0001404) | 2.57930419 |
| 71 | Increased intramyocellular lipid droplets (HP:0012240) | 2.57820010 |
| 72 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.55754153 |
| 73 | Palpitations (HP:0001962) | 2.55630637 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.54668470 |
| 75 | Focal motor seizures (HP:0011153) | 2.54352071 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.50772958 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.50727771 |
| 78 | Poor head control (HP:0002421) | 2.49940348 |
| 79 | Lactic acidosis (HP:0003128) | 2.49513199 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 2.48595948 |
| 81 | Glycosuria (HP:0003076) | 2.48595948 |
| 82 | Petechiae (HP:0000967) | 2.45464241 |
| 83 | Osteomyelitis (HP:0002754) | 2.44619139 |
| 84 | Optic disc pallor (HP:0000543) | 2.44370369 |
| 85 | Abnormality of serum amino acid levels (HP:0003112) | 2.43453333 |
| 86 | Inappropriate behavior (HP:0000719) | 2.42726735 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.42303194 |
| 88 | Respiratory failure (HP:0002878) | 2.36855597 |
| 89 | Constricted visual fields (HP:0001133) | 2.36124511 |
| 90 | Esophageal neoplasm (HP:0100751) | 2.34346750 |
| 91 | Neoplasm of head and neck (HP:0012288) | 2.34346750 |
| 92 | Periodontitis (HP:0000704) | 2.33763317 |
| 93 | Axonal loss (HP:0003447) | 2.32449400 |
| 94 | Abnormality of renal resorption (HP:0011038) | 2.31883078 |
| 95 | IgM deficiency (HP:0002850) | 2.31017902 |
| 96 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.31008973 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.28125852 |
| 98 | Abolished electroretinogram (ERG) (HP:0000550) | 2.27436643 |
| 99 | Dysostosis multiplex (HP:0000943) | 2.25590261 |
| 100 | Type I transferrin isoform profile (HP:0003642) | 2.24621275 |
| 101 | Hypoglycemic coma (HP:0001325) | 2.24522190 |
| 102 | Degeneration of anterior horn cells (HP:0002398) | 2.24064625 |
| 103 | Abnormality of the anterior horn cell (HP:0006802) | 2.24064625 |
| 104 | Urticaria (HP:0001025) | 2.19982651 |
| 105 | Nemaline bodies (HP:0003798) | 2.19950581 |
| 106 | Thick nail (HP:0001805) | 2.17914800 |
| 107 | Pustule (HP:0200039) | 2.16894785 |
| 108 | Large for gestational age (HP:0001520) | 2.16189059 |
| 109 | Recurrent lower respiratory tract infections (HP:0002783) | 2.13987420 |
| 110 | Fused cervical vertebrae (HP:0002949) | 2.13932212 |
| 111 | Increased mean platelet volume (HP:0011877) | 2.10706568 |
| 112 | Eosinophilia (HP:0001880) | 2.08852503 |
| 113 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.08163020 |
| 114 | Papillary thyroid carcinoma (HP:0002895) | 2.06260505 |
| 115 | Neuroendocrine neoplasm (HP:0100634) | 2.06143193 |
| 116 | Leukocytosis (HP:0001974) | 2.05313985 |
| 117 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05183658 |
| 118 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05183658 |
| 119 | Heterochromia iridis (HP:0001100) | 2.03663649 |
| 120 | Upper motor neuron abnormality (HP:0002127) | 2.03467558 |
| 121 | Chorioretinal atrophy (HP:0000533) | 2.03200383 |
| 122 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.02172385 |
| 123 | Pancreatitis (HP:0001733) | 2.01148428 |
| 124 | Arterial thrombosis (HP:0004420) | 2.00072713 |
| 125 | Metaphyseal dysplasia (HP:0100255) | 1.99888767 |
| 126 | Mutism (HP:0002300) | 1.99495182 |
| 127 | IgG deficiency (HP:0004315) | 1.97070378 |
| 128 | Muscle fiber inclusion bodies (HP:0100299) | 1.96194986 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.96169191 |
| 130 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.95977630 |
| 131 | Thrombocytosis (HP:0001894) | 1.95959231 |
| 132 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.95578955 |
| 133 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.95578955 |
| 134 | Glomerulonephritis (HP:0000099) | 1.95264663 |
| 135 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.95234349 |
| 136 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.94255171 |
| 137 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93497712 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.93173854 |
| 139 | Abnormal hair whorl (HP:0010721) | 1.93052687 |
| 140 | Hypoproteinemia (HP:0003075) | 1.91855523 |
| 141 | Increased serum lactate (HP:0002151) | 1.90332880 |
| 142 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88678208 |
| 143 | Vertebral compression fractures (HP:0002953) | 1.88535086 |
| 144 | Attenuation of retinal blood vessels (HP:0007843) | 1.88268986 |
| 145 | Congenital, generalized hypertrichosis (HP:0004540) | 1.87506550 |
| 146 | Short hallux (HP:0010109) | 1.87373216 |
| 147 | Increased muscle lipid content (HP:0009058) | 1.87223920 |
| 148 | Hemoptysis (HP:0002105) | 1.85397823 |
| 149 | Thyroiditis (HP:0100646) | 1.84612285 |
| 150 | Diminished motivation (HP:0000745) | 1.84591768 |
| 151 | Renal cortical cysts (HP:0000803) | 1.84256079 |
| 152 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83692721 |
| 153 | Thyroid carcinoma (HP:0002890) | 1.82938784 |
| 154 | Papilledema (HP:0001085) | 1.82589218 |
| 155 | Granulocytopenia (HP:0001913) | 1.81609756 |
| 156 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80071640 |
| 157 | Rimmed vacuoles (HP:0003805) | 1.79974667 |
| 158 | Mucosal telangiectasiae (HP:0100579) | 1.79862484 |
| 159 | Epistaxis (HP:0000421) | 1.79717091 |
| 160 | Mitochondrial inheritance (HP:0001427) | 1.79591969 |
| 161 | B lymphocytopenia (HP:0010976) | 1.78988086 |
| 162 | Encephalitis (HP:0002383) | 1.78782589 |
| 163 | Short phalanx of the thumb (HP:0009660) | 1.78557300 |
| 164 | Autoimmune hemolytic anemia (HP:0001890) | 1.77289105 |
| 165 | Abnormality of the basal ganglia (HP:0002134) | 1.77223001 |
| 166 | Widely spaced teeth (HP:0000687) | 1.76384126 |
| 167 | Abnormal platelet volume (HP:0011876) | 1.75911873 |
| 168 | Sepsis (HP:0100806) | 1.75576206 |
| 169 | Choroideremia (HP:0001139) | 1.75556205 |
| 170 | Neoplasm of the adrenal gland (HP:0100631) | 1.75294762 |
| 171 | Acanthocytosis (HP:0001927) | 1.74736741 |
| 172 | Exertional dyspnea (HP:0002875) | 1.74427229 |
| 173 | Abnormality of vitamin metabolism (HP:0100508) | 1.73897776 |
| 174 | Abnormality of eosinophils (HP:0001879) | 1.73627262 |
| 175 | Abnormal biliary tract morphology (HP:0012440) | 1.73023461 |
| 176 | Respiratory difficulties (HP:0002880) | 1.72394471 |
| 177 | Apathy (HP:0000741) | 1.72158238 |
| 178 | Congenital primary aphakia (HP:0007707) | 1.72032873 |
| 179 | Pulmonary fibrosis (HP:0002206) | 1.71531515 |
| 180 | Skin ulcer (HP:0200042) | 1.70748240 |
| 181 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.69601239 |
| 182 | Hypoplasia of the fovea (HP:0007750) | 1.69601239 |
| 183 | CNS demyelination (HP:0007305) | 1.69545355 |
| 184 | Memory impairment (HP:0002354) | 1.68109668 |
| 185 | Premature loss of primary teeth (HP:0006323) | 1.67881920 |
| 186 | Abnormality of T cell physiology (HP:0011840) | 1.67122454 |
| 187 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66484650 |
| 188 | Recurrent bronchitis (HP:0002837) | 1.66478283 |
| 189 | Hypothermia (HP:0002045) | 1.64597512 |
| 190 | Hypokinesia (HP:0002375) | 1.64527012 |
| 191 | Xerostomia (HP:0000217) | 1.64425523 |
| 192 | Palpebral edema (HP:0100540) | 1.64239779 |
| 193 | Atonic seizures (HP:0010819) | 1.62889889 |
| 194 | Acute necrotizing encephalopathy (HP:0006965) | 1.62410078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.99229974 |
| 2 | RIPK4 | 4.75800298 |
| 3 | MAP3K12 | 3.54511975 |
| 4 | MAP3K14 | 3.44702724 |
| 5 | TXK | 2.57083015 |
| 6 | FRK | 2.56238365 |
| 7 | BLK | 2.56006581 |
| 8 | MST4 | 2.53360476 |
| 9 | IRAK4 | 2.46862466 |
| 10 | TRIM28 | 2.31960934 |
| 11 | BMPR2 | 2.30533815 |
| 12 | KIT | 2.23212889 |
| 13 | PBK | 2.21647252 |
| 14 | CASK | 2.18967469 |
| 15 | TBK1 | 2.12384266 |
| 16 | ARAF | 2.03793169 |
| 17 | MAP4K1 | 1.90321656 |
| 18 | EIF2AK1 | 1.88367679 |
| 19 | PIM2 | 1.85148403 |
| 20 | PLK2 | 1.77922826 |
| 21 | TEC | 1.77696789 |
| 22 | CAMKK2 | 1.73159146 |
| 23 | TYK2 | 1.72101312 |
| 24 | SYK | 1.70196012 |
| 25 | WNK3 | 1.63624040 |
| 26 | MAP4K2 | 1.62283189 |
| 27 | CCNB1 | 1.58843075 |
| 28 | CSF1R | 1.54324304 |
| 29 | FES | 1.43143597 |
| 30 | IKBKE | 1.40837616 |
| 31 | DAPK1 | 1.40093253 |
| 32 | OBSCN | 1.38530555 |
| 33 | ERBB3 | 1.38207611 |
| 34 | SIK3 | 1.36785729 |
| 35 | IKBKB | 1.36171770 |
| 36 | GRK7 | 1.36006389 |
| 37 | NUAK1 | 1.34004563 |
| 38 | JAK3 | 1.33772016 |
| 39 | MAP3K13 | 1.31009940 |
| 40 | LYN | 1.23496743 |
| 41 | ZAK | 1.20727984 |
| 42 | MKNK2 | 1.18951710 |
| 43 | IRAK3 | 1.09171782 |
| 44 | GRK1 | 1.08607982 |
| 45 | MKNK1 | 1.07828535 |
| 46 | BTK | 1.03847413 |
| 47 | RAF1 | 1.03593930 |
| 48 | INSRR | 1.01981820 |
| 49 | YES1 | 1.01564240 |
| 50 | CDK19 | 1.01232996 |
| 51 | EIF2AK3 | 1.00112313 |
| 52 | MYLK | 0.99104525 |
| 53 | HCK | 0.98899361 |
| 54 | NEK1 | 0.98655291 |
| 55 | ZAP70 | 0.98001553 |
| 56 | ADRBK2 | 0.96179779 |
| 57 | STK16 | 0.93756696 |
| 58 | SRPK1 | 0.92887173 |
| 59 | LCK | 0.92719549 |
| 60 | JAK1 | 0.92199520 |
| 61 | PIK3CG | 0.91518134 |
| 62 | NEK9 | 0.91325033 |
| 63 | TSSK6 | 0.91315879 |
| 64 | EPHA4 | 0.90129722 |
| 65 | BMPR1B | 0.90070572 |
| 66 | MAP2K7 | 0.90058424 |
| 67 | OXSR1 | 0.89757223 |
| 68 | CLK1 | 0.87465559 |
| 69 | MATK | 0.85880172 |
| 70 | TRPM7 | 0.85526880 |
| 71 | FGR | 0.84620162 |
| 72 | EIF2AK2 | 0.84497890 |
| 73 | ACVR1B | 0.82768723 |
| 74 | MINK1 | 0.79674592 |
| 75 | MAP3K4 | 0.79346818 |
| 76 | CSNK1G1 | 0.78931862 |
| 77 | BUB1 | 0.78879890 |
| 78 | NTRK3 | 0.78825519 |
| 79 | STK39 | 0.78181094 |
| 80 | FER | 0.77796124 |
| 81 | STK3 | 0.75125801 |
| 82 | CSNK1A1L | 0.74718181 |
| 83 | TGFBR2 | 0.74362363 |
| 84 | MAPK13 | 0.74149911 |
| 85 | ITK | 0.73730929 |
| 86 | NME2 | 0.73183195 |
| 87 | TIE1 | 0.72421866 |
| 88 | CSNK1G3 | 0.71452199 |
| 89 | PRKCD | 0.71426925 |
| 90 | CSNK1G2 | 0.71287306 |
| 91 | BRSK2 | 0.69820365 |
| 92 | STK38L | 0.68046867 |
| 93 | MAP2K3 | 0.66105598 |
| 94 | ABL2 | 0.65536511 |
| 95 | PDK2 | 0.64086802 |
| 96 | PINK1 | 0.63679733 |
| 97 | PTK2B | 0.63318106 |
| 98 | CSK | 0.62892046 |
| 99 | MOS | 0.62230185 |
| 100 | ABL1 | 0.61655306 |
| 101 | TAOK3 | 0.61630210 |
| 102 | CAMKK1 | 0.60493938 |
| 103 | TESK1 | 0.60249666 |
| 104 | VRK1 | 0.60051857 |
| 105 | TGFBR1 | 0.58655884 |
| 106 | PRPF4B | 0.57945985 |
| 107 | PRKCQ | 0.56550051 |
| 108 | LIMK1 | 0.55324833 |
| 109 | NME1 | 0.53870417 |
| 110 | PLK4 | 0.52829767 |
| 111 | BCR | 0.51863723 |
| 112 | PHKG1 | 0.50812690 |
| 113 | PHKG2 | 0.50812690 |
| 114 | PAK3 | 0.50556419 |
| 115 | SCYL2 | 0.47937619 |
| 116 | FLT3 | 0.46987955 |
| 117 | GRK5 | 0.45967468 |
| 118 | STK24 | 0.44919189 |
| 119 | MST1R | 0.43745495 |
| 120 | ILK | 0.43576943 |
| 121 | MAP3K5 | 0.41268220 |
| 122 | CHUK | 0.40564848 |
| 123 | GRK6 | 0.40022840 |
| 124 | PRKCE | 0.39702551 |
| 125 | RPS6KA4 | 0.39060542 |
| 126 | PIM1 | 0.38361259 |
| 127 | CAMK2A | 0.37368310 |
| 128 | MARK3 | 0.37288496 |
| 129 | PDK1 | 0.36422918 |
| 130 | JAK2 | 0.35810890 |
| 131 | WEE1 | 0.35095491 |
| 132 | NLK | 0.34329041 |
| 133 | PLK3 | 0.33621126 |
| 134 | KSR1 | 0.33522125 |
| 135 | TAOK2 | 0.33110801 |
| 136 | CDK8 | 0.32981081 |
| 137 | TNIK | 0.32877593 |
| 138 | FYN | 0.32420676 |
| 139 | ADRBK1 | 0.32366797 |
| 140 | EGFR | 0.32075111 |
| 141 | EPHA3 | 0.32048555 |
| 142 | MAP3K9 | 0.31902022 |
| 143 | DAPK2 | 0.31631767 |
| 144 | IGF1R | 0.31175547 |
| 145 | CAMK2D | 0.29371629 |
| 146 | INSR | 0.28479864 |
| 147 | PRKG1 | 0.24990707 |
| 148 | PLK1 | 0.24808168 |
| 149 | MUSK | 0.23880133 |
| 150 | MAP2K6 | 0.23793194 |
| 151 | PRKCG | 0.23494545 |
| 152 | CAMK2G | 0.22348455 |
| 153 | IRAK1 | 0.21841227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.58999103 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.13941039 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.76820564 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72162064 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.51388702 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.30892944 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.29430783 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.29423596 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.26510730 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 2.18252855 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.14840920 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.11962247 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.10838788 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.10259004 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.08043805 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.03272731 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.03236556 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.93723505 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87624782 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85022003 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83795148 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.81472571 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.77587576 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.75203973 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74791519 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.73450340 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73153103 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66699091 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66510218 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.66283885 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.65937558 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.65469021 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.64560674 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62011021 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.60565170 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60166112 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58585743 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58238349 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.54939092 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54168471 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.52958543 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.52676700 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.51911150 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51099535 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48468433 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41749931 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41052564 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38647252 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.36950323 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.36159954 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35901827 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.34426606 |
| 53 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.32043554 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 1.31078534 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30134494 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29746350 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 1.27701201 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.27587139 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23055318 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22275276 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21928653 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19919220 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 1.19150654 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17645924 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.17502855 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17301016 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16243422 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14424742 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11003884 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10850291 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10309742 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08808026 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08686519 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08025949 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06467127 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06316225 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04611238 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03728568 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 1.01421459 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00265400 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00198863 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00011918 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.98295945 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97248998 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97151980 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96347500 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.89765131 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.89259842 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88741760 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88373147 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.87386812 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87122754 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86113161 |
| 94 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86083403 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.85782812 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85036618 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83678256 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83432990 |
| 99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83362282 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83330186 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82305718 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81731202 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.81289099 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80801208 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80105027 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79896341 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77203247 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77005998 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75727153 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75357593 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75204601 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.74276534 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73833843 |
| 114 | Platelet activation_Homo sapiens_hsa04611 | 0.72699382 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72671257 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.71698624 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71160666 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69812426 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66575177 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65542625 |
| 121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64492038 |
| 122 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.62887466 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61684670 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61106759 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61014196 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60129820 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | 0.57762873 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57754576 |
| 129 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56281542 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55222569 |
| 131 | Morphine addiction_Homo sapiens_hsa05032 | 0.54588469 |
| 132 | Protein export_Homo sapiens_hsa03060 | 0.53315493 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52531733 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51173277 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49573978 |
| 136 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49153520 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49077306 |
| 138 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48826229 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48509817 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48462747 |
| 141 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47820434 |
| 142 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47325758 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46191150 |
| 144 | Renin secretion_Homo sapiens_hsa04924 | 0.45763213 |
| 145 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45443201 |
| 146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45332194 |
| 147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45082650 |
| 148 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44925814 |
| 149 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43392528 |
| 150 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41528307 |
| 151 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.41478022 |
| 152 | Salivary secretion_Homo sapiens_hsa04970 | 0.41258021 |
| 153 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40971718 |
| 154 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40414679 |
| 155 | Amoebiasis_Homo sapiens_hsa05146 | 0.39268326 |
| 156 | Long-term depression_Homo sapiens_hsa04730 | 0.38696647 |
| 157 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38310157 |
| 158 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36967198 |
| 159 | Prion diseases_Homo sapiens_hsa05020 | 0.36457780 |
| 160 | * Endocytosis_Homo sapiens_hsa04144 | 0.36143290 |
| 161 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34339767 |
| 162 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33701758 |
| 163 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32757546 |
| 164 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32187588 |
| 165 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32181905 |
| 166 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30887527 |
| 167 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29897764 |
| 168 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28890016 |
| 169 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27365490 |
| 170 | DNA replication_Homo sapiens_hsa03030 | 0.26702577 |
| 171 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.25959878 |

